Journal article · 2026 · Open access

Tumor-reactive LAG3+CD8+ T cells diverge into terminally exhausted cells and long-lived memory T cells

Vaishali Aggarwal, Yangxi Sun, Chang Liu, Jian Cui, Sasikanth Manne, Yu Dou, Qiang Chen, Erin A. Brunazzi, Kate M. Vignali, Haiguang Wang, E. John Wherry, Creg J. Workman and 1 more

The Journal of Experimental Medicine, 223(9) · Published 16 July 2026 · DOI 10.1084/jem.20241968

Open PDFView at the publisherCite this paper

In brief

“Tumor-reactive LAG3+CD8+ T cells diverge into terminally exhausted cells and long-lived memory T cells” is a 2026 journal article by Vaishali Aggarwal and 12 co-authors, published in The Journal of Experimental Medicine. OpenAlex counts 0 citations as of 18 November 2026. It is open access: the full text is free to read at The Journal of Experimental Medicine.

Citations
0
References
56
Authors
13

Abstract

Chronic T cell stimulation in tumors and chronic viral infections leads to T cell exhaustion, a state of dysfunction. As LAG3 marks a prominent subset of exhausted T (TEX) cells in mid-to-late stage tumors, we generated a Lag3 lineage-tracing mouse model (Lag3iCreERT2Rosa26LSL-tdTomato) to fate map and characterize tumor-reactive LAG3+CD8+ TEX cells. In tumor-bearing mice, two distinct tumor-specific tdTomato+ CD8+ T cell subsets stratified by LAG3 surface expression (LAG3+tdT+ and LAG3-tdT+) exhibited contrasting anatomical distributions, functionality and transcriptional profiles, yet shared TCR clonotypes, suggesting a common origin. While LAG3+tdT+ CD8+ TEX cells were restricted to the tumor microenvironment and predominantly terminally exhausted, LAG3-tdT+ CD8+ TEX cells were progenitors that persisted in vivo and are required for anti-tumor immunity against a secondary tumor challenge. This study highlights TEX cell functional heterogeneity and plasticity and characterizes a unique fate-flexible LAG3-tdT+ progenitor TEX subset that drives an anti-tumor memory response, supporting antibody-based therapeutic targeting of LAG3+ TEX cells to unleash anti-tumor immunity and promote durability.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Aggarwal, V., Sun, Y., Liu, C., Cui, J., Manne, S., Dou, Y., Chen, Q., Brunazzi, E. A., Vignali, K. M., Wang, H., Wherry, E. J., Workman, C. J., & Vignali, D. A. (2026). Tumor-reactive LAG3+CD8+ T cells diverge into terminally exhausted cells and long-lived memory T cells. The Journal of Experimental Medicine, 223(9). https://doi.org/10.1084/jem.20241968

MLA 9

Aggarwal, Vaishali, et al. “Tumor-reactive LAG3+CD8+ T cells diverge into terminally exhausted cells and long-lived memory T cells.” The Journal of Experimental Medicine, vol. 223, no. 9, 2026. https://doi.org/10.1084/jem.20241968.

Chicago

Aggarwal, Vaishali, Yangxi Sun, Chang Liu, Jian Cui, Sasikanth Manne, Yu Dou, Qiang Chen, et al. 2026. “Tumor-reactive LAG3+CD8+ T cells diverge into terminally exhausted cells and long-lived memory T cells.” The Journal of Experimental Medicine 223 (9). https://doi.org/10.1084/jem.20241968.

Harvard

Aggarwal, V. et al. (2026) ‘Tumor-reactive LAG3+CD8+ T cells diverge into terminally exhausted cells and long-lived memory T cells’, The Journal of Experimental Medicine, 223(9). doi:10.1084/jem.20241968.

IEEE

V. Aggarwal et al., “Tumor-reactive LAG3+CD8+ T cells diverge into terminally exhausted cells and long-lived memory T cells,” The Journal of Experimental Medicine, vol. 223, no. 9, 2026, doi: 10.1084/jem.20241968.

BibTeX

@article{aggarwal2026tumor,
  title     = {{Tumor-reactive LAG3+CD8+ T cells diverge into terminally exhausted cells and long-lived memory T cells}},
  author    = {Aggarwal, Vaishali and Sun, Yangxi and Liu, Chang and Cui, Jian and Manne, Sasikanth and Dou, Yu and Chen, Qiang and Brunazzi, Erin A. and Vignali, Kate M. and Wang, Haiguang and Wherry, E. John and Workman, Creg J. and Vignali, Dario A.A.},
  journal   = {The Journal of Experimental Medicine},
  year      = {2026},
  volume    = {223},
  number    = {9},
  doi       = {10.1084/jem.20241968},
  url       = {https://doi.org/10.1084/jem.20241968}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers

  • LAG-3
  • T cell exhaustion
  • CD8+ T cells
  • tumor-reactive T cells
  • lineage tracing
  • memory T cells
  • antitumor immunity
  • tumor microenvironment

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Aggarwal, V., Sun, Y., Liu, C., Cui, J., Manne, S., Dou, Y., Chen, Q., Brunazzi, E. A., Vignali, K. M., Wang, H., Wherry, E. J., Workman, C. J., & Vignali, D. A. (2026). Tumor-reactive LAG3+CD8+ T cells diverge into terminally exhausted cells and long-lived memory T cells. The Journal of Experimental Medicine, 223(9). https://doi.org/10.1084/jem.20241968

How many times has this paper been cited?

0 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at The Journal of Experimental Medicine: sign in and open the PDF from this page.

Who wrote this paper?

Vaishali Aggarwal, Yangxi Sun, Chang Liu, Jian Cui, Sasikanth Manne, Yu Dou, Qiang Chen, Erin A. Brunazzi, Kate M. Vignali, Haiguang Wang, E. John Wherry, Creg J. Workman and 1 more.

What is the DOI of this paper?

10.1084/jem.20241968, permanently at https://doi.org/10.1084/jem.20241968. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.